Record July Revenue Reinforces AI Demand, but Margin Overhang Caps Near-Term Upside

What happened

TSMC’s July revenue vaulted to a record NT$467.6 billion, up 44.7% year-over-year, marking a seventh consecutive month of AI-driven acceleration. Management reiterated its full-year 2026 revenue growth target of slightly above 40% in U.S. dollars, signaling confidence that hyperscaler demand remains robust. Despite the beat, the stock sits 13% below its all-time high, reflecting persistent investor unease over the gross-margin dilution expected from the 2-nanometer ramp and overseas fab expansions. The print is consistent with our bull scenario for top-line momentum but does not alter the near-term margin compression issue that limits valuation support near the current $402 level. With the base-case implied value around $410, the risk/reward appears finely balanced, and no immediate catalyst from this data alone justifies a rating change.

Implication

July’s record revenue demonstrates that TSMC’s advanced-node and packaging capacity remains fully utilized, supporting management’s confident full-year growth outlook. However, the stock’s 13% decline from its peak underscores the market’s preoccupation with the upcoming gross-margin compression from the 2nm ramp and overseas fab costs, which are expected to dilute margins by 2–3% this year. The WAIT rating is maintained because the current price already embeds durable AI demand, and the next catalyst requires concrete evidence that margins can hold above 66% despite rising capex intensity. A positive re-rating would likely follow if packaging tightness endures and 3nm profitability exceeds the corporate average, but those data points are still months away. Until then, investors should treat any rally toward $460 as an opportunity to trim and view a pullback toward $360 as a more attractive entry for fresh positions.

Thesis delta

TSMC’s July revenue and full-year guidance reaffirm the bull case for sustained AI demand, consistent with our base and bull scenarios. However, the data does not address the market’s primary concern—the trajectory of gross margins amid 2nm and overseas ramp dilution—and therefore does not alter the WAIT rating. The thesis remains unchanged until we see evidence of margin stabilization or a clearer path to earnings growth outpacing spending intensity.